137 related articles for article (PubMed ID: 29273724)
1. Worsened outcome in patients with pancreatic ductal carcinoma on long-term diabetes: association with E-cadherin1 (CDH1) promoter methylation.
Saito T; Mizukami H; Umetsu S; Uchida C; Inaba W; Abe M; Takahashi K; Kudo K; Itabashi C; Yagihashi S; Hakamada K
Sci Rep; 2017 Dec; 7(1):18056. PubMed ID: 29273724
[TBL] [Abstract][Full Text] [Related]
2. Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis.
Hara Y; Mizukami H; Yamazaki K; Yamada T; Igawa A; Takeuchi Y; Sasaki T; Kushibiki H; Murakami K; Kudoh K; Ishido K; Hakamada K
J Pathol Clin Res; 2023 Sep; 9(5):354-366. PubMed ID: 37246239
[TBL] [Abstract][Full Text] [Related]
3. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
[TBL] [Abstract][Full Text] [Related]
4. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
5. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
6. Resolution of new-onset diabetes after radical pancreatic resection predicts long-term survival in patients with pancreatic ductal cell adenocarcinoma.
He XY; Li JF; Yao WY; Yuan YZ
Ann Surg Oncol; 2013 Nov; 20(12):3809-16. PubMed ID: 23943021
[TBL] [Abstract][Full Text] [Related]
7. [Promoter methylation profile in breast cancer].
Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I
Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
[TBL] [Abstract][Full Text] [Related]
9. [Effects of CDH1 gene promoter methylation on expression of E-cadherin and beta-catenin and its clinicopathological significance in colon carcinoma].
Li C; Dong J; Chen MQ; Li WL; Ren JY; Chen SX; Li QT; Geng JW; Miao YD; Yang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jul; 14(7):538-41. PubMed ID: 21792768
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
11. [Gastric carcinoma and chronic gastritis: epigenetic regulation of CDH1 (E-Cadherin), CDKN2A (p16INK4A), PTGS2 (COX-2) and EGFR genes through methylation].
Silva M; Azenha D; Pereira C; Almeida A; Balseiro S; Sampaio AM; Santos P; Carvalho L
Acta Med Port; 2010; 23(1):5-14. PubMed ID: 20353702
[TBL] [Abstract][Full Text] [Related]
12. Promoter methylation and expression of CDH1 and susceptibility and prognosis of eyelid squamous cell carcinoma.
Wang YQ; Yuan Y; Jiang S; Jiang H
Tumour Biol; 2016 Jul; 37(7):9521-6. PubMed ID: 26790440
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma.
Machado JC; Oliveira C; Carvalho R; Soares P; Berx G; Caldas C; Seruca R; Carneiro F; Sobrinho-Simöes M
Oncogene; 2001 Mar; 20(12):1525-8. PubMed ID: 11313896
[TBL] [Abstract][Full Text] [Related]
15. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer.
Aghdassi A; Sendler M; Guenther A; Mayerle J; Behn CO; Heidecke CD; Friess H; Büchler M; Evert M; Lerch MM; Weiss FU
Gut; 2012 Mar; 61(3):439-48. PubMed ID: 22147512
[TBL] [Abstract][Full Text] [Related]
17. [Gene methylation patterns in digestive tumors].
Roa S JC; García M P; Melo A A; Tapia E O; Villaseca H M; Araya O JC; Guzmán G P
Rev Med Chil; 2008 Apr; 136(4):451-8. PubMed ID: 18769787
[TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.
Xia L; Hu Y; Gu T; Wang L; Tian Z
Int J Oncol; 2018 Feb; 52(2):496-504. PubMed ID: 29207084
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue.
Celebiler Cavusoglu A; Sevinc AI; Saydam S; Canda T; Baskan Z; Kilic Y; Sakizli M
Neoplasma; 2010; 57(5):465-72. PubMed ID: 20568901
[TBL] [Abstract][Full Text] [Related]
20. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
De Schutter H; Geeraerts H; Verbeken E; Nuyts S
Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
